. . . . . .
.
 
Pharma glossary
 
Where sensible, glossary terms have been grouped and defined together so you can compare and contrast similar (and opposite) terms together, e.g. research questions; research interviews; rating scales.

A
| B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z|

Search the glossary   
US spelling

G

Gabor Granger (see Pricing Research)

GCP
Good Clinical Practice
. Quality assurance guidelines within clinical research.

Generic Products
Drugs manufactured by other than the originator (patent holder) and usually sold un-branded.

Generic Strategy
Strategies to protect/limit erosion of branded product by generics, designed in advance of patent expiry.

Geodemographics
The classification of a population based on multivariate analysis of data (e.g. classification of a population by the social grade associated with neighborhoods).

Global Health Index
A single-number health status index derived from the assessment of all domains of health-related quality of life.

Global Positioning, Branding, Advertising, etc
Consistent strategy and programs deployed throughout the world, usually with some scope for local adaptation - a growing trend.

Go / No Go Criteria
Minimum criteria which a new product needs to fulfill in order to be considered for further clinical development and investment.

Gompertz
A curve used to describe the 'typical' uptake of a new product in the market. Defined by the length of time to reach its maximum value, and the maximum value, the Gompertz curve formula rises to reach the peak value. The Gompertz formula does not allow the curve to decline.

 
 
Contact Us | Site Map | FAQs | Search | Print | Recommend this site | Offices | Privacy, Copyright & Legal | Bookmark this site